BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai G, He D, Chu L, Dai Q, Xu Z, Zhang Y. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature. Int J Neurosci 2016;126:660-8. [PMID: 26010208 DOI: 10.3109/00207454.2015.1054481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Maiorca C, Moret F, Martines V, Tramontano D, Papassifachis MA, Bini S, Caramazza C, Fontana M, Lucia P, Inghilleri M. Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case Report. Front Med 2022;8:743798. [DOI: 10.3389/fmed.2021.743798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ding M, Lang Y, Cui L. AQP4-IgG positive paraneoplastic NMOSD: A case report and review. Brain Behav 2021;11:e2282. [PMID: 34520629 DOI: 10.1002/brb3.2282] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Virgilio E, Vecchio D, Vercellino M, Naldi P, Tesser F, Cantello R, Cavalla P, Comi C. Paraneoplastic neuromyelitis optica spectrum disorders: a case series. Neurol Sci 2021;42:2519-22. [PMID: 33506301 DOI: 10.1007/s10072-021-05055-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yuan J, Jia Z, Qin W, Hu W. Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer. Clin Interv Aging 2019;14:1039-44. [PMID: 31239653 DOI: 10.2147/CIA.S202102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
5 Sachdeva J, Bansal R, Takkar A, Singh R. Neuromyelitis optica spectrum disorder and adenocarcinoma of ovary: a novel association. BMJ Case Rep 2019;12:e227435. [PMID: 31023729 DOI: 10.1136/bcr-2018-227435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wendebourg MJ, Nagy S, Derfuss T, Parmar K, Schlaeger R. Magnetic resonance imaging in immune-mediated myelopathies. J Neurol 2020;267:1233-44. [PMID: 30694379 DOI: 10.1007/s00415-019-09206-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Zarei S, Eggert J, Franqui-Dominguez L, Carl Y, Boria F, Stukova M, Avila A, Rubi C, Chinea A. Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico. Surg Neurol Int 2018;9:242. [PMID: 30603227 DOI: 10.4103/sni.sni_224_18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
8 Schattner A, Voichanski S, Uliel L. SLE presenting as demyelinative autoimmune visual loss. BMJ Case Rep 2018;2018:bcr-2017-222158. [PMID: 29507012 DOI: 10.1136/bcr-2017-222158] [Reference Citation Analysis]
9 Sepúlveda M, Sola-Valls N, Escudero D, Rojc B, Barón M, Hernández-Echebarría L, Gómez B, Dalmau J, Saiz A, Graus F. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies. Mult Scler 2018;24:1753-9. [PMID: 28920766 DOI: 10.1177/1352458517731914] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 7.8] [Reference Citation Analysis]
10 Obeidat AZ, Jacob C, Zabeti A. Concurrent Dawson's Fingers and Area Postrema Lesion in a Mixed Neuroimmune Disorder. Can J Neurol Sci 2017;44:452-4. [PMID: 28091334 DOI: 10.1017/cjn.2016.427] [Reference Citation Analysis]
11 Berger B, Hottenrott T, Rauer S, Stich O. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders. BMC Neurol 2017;17:5. [PMID: 28068933 DOI: 10.1186/s12883-016-0779-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]